Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

Overview of attention for article published in Journal for Immunotherapy of Cancer, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 10 tweeters

patent: 1 patent

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 49 Mendeley

Summary Twitter Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

GENETICALLY ENGINEERED DOUBLE NEGATIVE T CELLS AS AN ADOPTIVE CELLULAR THERAPY

Application WO-2021108926-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.